All results - Medicines Current Awareness - NHS England - Royal Pharmaceutical Society | Evidence search

View all results Displaying only NeLM Medicines NewMASPrimary Policy for your search

Click export CSV or RIS to download the entire page or use the checkboxes to select a subset of records to download

Clinical Commissioning Policy: Human coagulation factor X for hereditary factor X deficiency (all ages) [PDF]

Remove: NHS England source - 06 March 2020 - Publisher: NHS England

NHS England will commission human coagulation factor X in hereditary factor X deficiency (all ages) in accordance with the criteria outlined within the commissioning document.

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Clinical Commissioning Policy: Vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease

Remove: NHS England source - 06 March 2020 - Publisher: NHS England

NHS England has reviewed evidence for vonicog alfa and concluded that it is not for routine commissioning for the treatment and prevention of bleeding in adults with von Willebrand disease.

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Clinical Commissioning Policy: Temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (Adults)

Remove: NHS England source - 06 March 2020 - Publisher: NHS England

NHS England will commission temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults) in...

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Transitions from adolescent secure to adult secure inpatient services: Practice guidance for all secure services [PDF]

Remove: NHS England source - 06 March 2020 - Publisher: NHS England

This guidance aims to outline good practice standards and give clear guidance for the positive transition of young people from adolescent secure inpatient units to adult secure inpatient units.

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Mental health policy in England [PDF]

Remove: House of Commons source - 01 August 2017 - Publisher: House of Commons

Around one in four people in the UK suffer from a mental health problem each year, but mental illness often goes untreated, and historically, treatment options for mental health compare...

Read Summary

- More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Novel Coronavirus: Advice for the NHS in England (updated 10th March)

Remove: NHS England source - 10 March 2020 - Publisher: NHS England

Updated advice now states that to improve case detection in those with no geographic link, patients requiring admission should be tested regardless of travel history if they have...

Remove: Medicines Current Awareness filter

- More: Safety Alerts
Dolutegravir-rilpivirine for treating HIV-1 in adults

Remove: NHS England source - 12 March 2020 - Publisher: NHS England

NHS England has reviewed evidence prepared by NICE and concluded that there is enough evidence to commission dolutegravir-rilpivirine for treating HIV-1 in adults in accordance with the criteria...

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Dolutegravir / lamivudine for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age

Remove: NHS England source - 12 March 2020 - Publisher: NHS England

Dolutegravir/lamivudine for the treatment of HIV infected adults and adolescents >12 years of age is recommended to be available as a treatment option through routine commissioning within the...

More: Policy and Strategy

- Remove: Medicines Current Awareness filter
Alert regarding appropriate rate for oxygen usage issued

Remove: NHS England source - 07 April 2020 - Publisher: NHS England

With hospitals now treating a large proportion of inpatients for COVID19 infection, the draw of oxygen from the storage tank is exceptionally high and may result in some hospitals drawing more oxygen...

SPS comment

- Remove: Medicines Current Awareness filter

- More: Safety Alerts
NHS England Speciality Guide: Clinical guide for the management of anticoagulant services during the coronavirus pandemic [PDF]

Remove: NHS England source - 31 March 2020 - Publisher: NHS England

This guide contains advice on continuing the safe provision of anticoagulant services, while protecting resources for the response to coronavirus. It notes that the way anticoagulants are delivered...

More: Policy and Strategy

- Remove: Medicines Current Awareness filter

Filter results by

Results for all evidence | Medicines Current Awareness | NHS England 21 - 30 of 91 sorted by relevance / date

Clinical Commissioning Policy: Human coagulation factor X for hereditary factor X deficiency (all ages) [PDF]

Clinical Commissioning Policy: Vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease

Clinical Commissioning Policy: Temozolomide as adjuvant treatment for people with newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (Adults)

Transitions from adolescent secure to adult secure inpatient services: Practice guidance for all secure services [PDF]

Mental health policy in England [PDF]

Novel Coronavirus: Advice for the NHS in England (updated 10th March)

Dolutegravir-rilpivirine for treating HIV-1 in adults

Dolutegravir / lamivudine for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age

Alert regarding appropriate rate for oxygen usage issued

NHS England Speciality Guide: Clinical guide for the management of anticoagulant services during the coronavirus pandemic [PDF]